James Yoo to Treatment Outcome
This is a "connection" page, showing publications James Yoo has written about Treatment Outcome.
Connection Strength
0.214
-
Cho KS, Ko IK, Yoo JJ. Bioactive Compounds for the Treatment of Renal Disease. Yonsei Med J. 2018 Nov; 59(9):1015-1025.
Score: 0.092
-
Atala A, Danilevskiy M, Lyundup A, Glybochko P, Butnaru D, Vinarov A, Yoo JJ. The potential role of tissue-engineered urethral substitution: clinical and preclinical studies. J Tissue Eng Regen Med. 2017 01; 11(1):3-19.
Score: 0.075
-
Choi JY, Chun SY, Kim BS, Kim HT, Yoo ES, Shon YH, Lim JO, Yun SJ, Song PH, Chung SK, Yoo JJ, Kwon TG. Pre-clinical efficacy and safety evaluation of human amniotic fluid-derived stem cell injection in a mouse model of urinary incontinence. Yonsei Med J. 2015 May; 56(3):648-57.
Score: 0.018
-
Kim BS, Chun SY, Lee JK, Lim HJ, Bae JS, Chung HY, Atala A, Soker S, Yoo JJ, Kwon TG. Human amniotic fluid stem cell injection therapy for urethral sphincter regeneration in an animal model. BMC Med. 2012 Aug 21; 10:94.
Score: 0.015
-
Raya-Rivera A, Esquiliano DR, Yoo JJ, Lopez-Bayghen E, Soker S, Atala A. Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet. 2011 Apr 02; 377(9772):1175-82.
Score: 0.014